Abnormal Expression of a 170-Kilodalton P-Glycoprotein Encoded byMDR1Gene, a Metabolically Active Efflux Pump, in CD4+and CD8+T Cells from Patients with Human Immunodeficiency Virus Type 1 Infection
- 10 October 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 12 (15) , 1457-1462
- https://doi.org/10.1089/aid.1996.12.1457
Abstract
Peripheral blood CD4+ and CD8+ T cells from 16 patients with HIV-1 infection, 8 each with CD4+ T cell counts of >200/mm3 (group I) and with CD4+ T cell counts of 3 (group II), and 8 age- and sex-matched controls, were examined for the expression of P-glycoprotein (P-gp), a 170-kDa phosphoglycoprotein encoded by the MDR1 gene, using dual-color flow cytometric analysis. The function of P-glycoprotein was assessed by the accumulation of rhodamine-123 (Rh123) dye in the presence or absence of cyclosporin A (which inhibits Rh123 efflux). A significantly increased proportion of CD4+ T cells from patients with HIV-1 infection expressed P-glycoprotein as compared to controls, resulting in a significantly increased ratio of the proportions of CD4+P-gp+/CD8+P-gp+ cells. The ratio of CD4+P-gp+/CD8+P-gp+ in group II patients was significantly higher (p = 0.02) than in group I patients, suggesting a progressive increase in P-gp expression with the advancement of HIV-1 infection. The proportions of CD4+P-gp+ and CD8+P-gp+ T cells did not differ significantly between those who received AZT and those who were not treated with AZT. Contrary to expectation, both CD4+ and CD8+ T cells from patients accumulated significantly more Rh123 as compared to controls. Furthermore, cyclosporin A failed to increase intracellular accumulation of Rh123 in CD4+ and CD8+ T cells from patients. These data suggest a functionally defective P-gp expression in HIV-1 infection that appears to increase with the progression of HIV-1 infection. A study of a large number of patients with HIV-1 infection is needed to determine the effects of opportunistic infection and antiretroviral therapy on the expression of P-gp and to determine whether the expression of P-gp could serve as another surrogate marker for the progression of HIV-1 infection.Keywords
This publication has 27 references indexed in Scilit:
- Mycobacterium tuberculosis Induces Expression of P-Glycoprotein in Promonocytic U1 Cells Chronically Infected with HIV Type 1Biochemical and Biophysical Research Communications, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Induction of Multidrug Resistance in Human Cells by Transient Exposure to Different Chemotherapeutic DrugsJNCI Journal of the National Cancer Institute, 1993
- Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8 + T cells: A role in cytotoxic effector functionJournal of Clinical Immunology, 1992
- Resistance of HIV-1 to AZT Might Also Involve the Cellular Expression of Multidrug Resistance P-GlycoproteinAIDS Research and Human Retroviruses, 1992
- Multidrug resistance activity in human lymphocytesHuman Immunology, 1991
- Multidrug Resistance: A Novel Class of Membrane-Associated Transport Proteins is IdentifiedCancer Investigation, 1991
- Human immunodeficiency virus I-induced expression of P-glycoproteinBiochemical and Biophysical Research Communications, 1990
- Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cellsBiochemical and Biophysical Research Communications, 1990
- Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selectionExperimental Cell Research, 1989